» Articles » PMID: 21347644

Epidemiology of Primary Immune Thrombocytopenia in Children and Adults in Japan: a Population-based Study and Literature Review

Overview
Journal Int J Hematol
Specialty Hematology
Date 2011 Feb 25
PMID 21347644
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The epidemiology of primary immune thrombocytopenia (ITP) is not well-characterized in the general population. Most published studies, which have included relatively small numbers of ITP patients, have been conducted in England or Scandinavian countries. No epidemiologic data from Asian countries have been published. This study describes the epidemiology of ITP in a Japanese population. We analyzed the database registry of the Ministry of Health, Labour, and Welfare of Japan, and extracted newly diagnosed acute and chronic ITP patients with a platelet count of <100 × 10(9)/L. From 2004 to 2007, 7,774 cases of ITP were reported, giving an overall incidence of 2.16/100,000/year. The incidence differed greatly between males and females, being 1.72 and 2.58, respectively. The median age of the total affected population was 56 years old. In male patients, there was a striking preponderance of boys below 4 years and a very high peak among those aged 75-89 years. In female patients, the number of ITP patients appeared to show a trimodal distribution by age, with the first peak representing patients below 4 years, the second peak those aged 20-34 years, and the third peak those aged 50-89 years. In conclusion, the incidence of ITP in Japan is not markedly different from that of European countries studied to date. This population-based study reveals that, contrary to previously published studies, the maximum age-specific incidence is in the eighth decade.

Citing Articles

Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan.

Kashiwagi H, Miura I, Terasawa N, Iwayama K, Furukawa Y, Kanenishi M Int J Hematol. 2024; 121(3):363-377.

PMID: 39668284 PMC: 11861122. DOI: 10.1007/s12185-024-03897-8.


Treatment outcomes and adherence to treatment in patients with immune thrombocytopenia in two Ethiopian teaching hospitals: a retrospective cohort study.

Beyene D, Sisay E, Fentie A, Gebremedhin A Sci Rep. 2024; 14(1):11917.

PMID: 38789461 PMC: 11126412. DOI: 10.1038/s41598-024-62372-w.


Epidemiology of immune thrombocytopenia: study of adult patients at a referral hematology service in Northeastern Brazil.

Kubrusly B, Kubrusly E, Rocha H, Brazil Viana Junior A, Kubrusly M, Ribeiro L Hematol Transfus Cell Ther. 2024; 46 Suppl 5:S152-S157.

PMID: 38177057 PMC: 11670561. DOI: 10.1016/j.htct.2023.09.2363.


An Epidemiology Study of Adult Immune Thrombocytopenia Patients in a Teaching Hospital in Northeastern Malaysia.

Zahidin M, Abdul Razak N, Noor N, Johan M, Zulkafli Z, Abdullah A Cureus. 2023; 15(11):e48533.

PMID: 38073971 PMC: 10709214. DOI: 10.7759/cureus.48533.


Immune Thrombocytopenic Purpura in an Adult Male: A Case Report.

Chhetri S, Kunwor B, Sharma B, Joshi P, Timilsina S Cureus. 2023; 15(10):e46664.

PMID: 37942396 PMC: 10628603. DOI: 10.7759/cureus.46664.


References
1.
Zaki M, Hassanein A, Khalil A . Childhood idiopathic thrombocytopenic purpura: report of 60 cases from Kuwait. J Trop Pediatr. 1990; 36(1):10-3. DOI: 10.1093/tropej/36.1.10. View

2.
George J, Woolf S, Raskob G, Wasser J, Aledort L, Ballem P . Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88(1):3-40. View

3.
Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K . Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol. 2000; 17(7):551-8. DOI: 10.1080/08880010050122816. View

4.
Neylon A, Saunders P, Howard M, Proctor S, Taylor P . Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol. 2003; 122(6):966-74. DOI: 10.1046/j.1365-2141.2003.04547.x. View

5.
McMillan R, Wang L, Tomer A, Nichol J, Pistillo J . Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2003; 103(4):1364-9. DOI: 10.1182/blood-2003-08-2672. View